These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6156900)

  • 1. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.
    Laragh JH; Case DB; Atlas SA; Sealey JE
    Hypertension; 1980; 2(4):586-93. PubMed ID: 6156900
    [No Abstract]   [Full Text] [Related]  

  • 2. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
    MacGregor GA; Markandu ND; Roulston JE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():145s-148s. PubMed ID: 396068
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
    Antonaccio MJ; Kerwin L
    Hypertension; 1981; 3(3 Pt 2):I54-62. PubMed ID: 6167515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of captopril, propranolol, and indomethacin on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats.
    Antonaccio MJ; Harris D; Goldenberg H; High JP; Rubin B
    Proc Soc Exp Biol Med; 1979 Dec; 162(3):429-33. PubMed ID: 390537
    [No Abstract]   [Full Text] [Related]  

  • 6. The renin/angiotensin system.
    Lee MR
    Br J Clin Pharmacol; 1981 Nov; 12(5):605-12. PubMed ID: 6174135
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
    Baker KM; Johns DW; Vaughan ED; Ayers CR; Carey RM
    Clin Exp Hypertens (1978); 1980; 2(6):947-54. PubMed ID: 7004807
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
    Hutchinson JS; Mendelsohn FA; Doyle AE
    Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
    Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
    Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response.
    Case DB; Atlas SA; Laragh JH; Sullivan PA; Sealey JE
    J Cardiovasc Pharmacol; 1980; 2(4):339-46. PubMed ID: 6156332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)].
    Ogihara T; Maruyama A; Mikami H; Naka T; Higaki J; Kanda T; Gotoh M; Hata T; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1185-92. PubMed ID: 396402
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
    Păuşescu E
    Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225).
    Weed WC; Vaughan ED; Peach MJ
    Hypertension; 1979; 1(1):8-12. PubMed ID: 397195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.